When it comes to primary sites, we found that the OS of right‐sided CRC (RCRC) patients was poorer than the left‐sided ones in KRAS mutation group (47.5 vs 87.9 months), though the result was not statistically significant (P = .157). The gene discussed is KRAS; the disease is colorectal carcinoma.